Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1271208

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1271208

Veterinary Dermatology Drugs Market, By Type of Drug, By Animal Type, And by Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

PUBLISHED:
PAGES: 168 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 7000
PDF (Enterprise User License)
USD 10000

Add to Cart

Veterinary dermatology drugs are therapeutics used for the treatment of skin diseases in animals. These drugs are formulated to treat skin cancer, bacterial infections, and parasitic infestations. The emergence of enhanced veterinary medical services has enabled veterinarians to offer a wide range of treatment options for various chronic and infectious diseases. These technologies have made veterinary medical services more convenient and cost-effective for both veterinarians and pet owners.

Market Dynamics:

The veterinary dermatology drugs market is expected to witness significant growth in the future due to the rising awareness about animal health among pet owners. Additionally, changes in the ecology of parasite habitat, climate change, increase in vector-host interactions, the introduction of foreign species in endemic areas, and high risk of vector-borne infection outside traditional endemic areas are also expected to drive the global veterinary dermatology drugs market growth. Moreover, advancements in technology for better molecular diagnostics and treatments are further anticipated to propel veterinary dermatology drug market growth.

On the contrary, strict approval regulations and side effects associated with the drugs are expected to restrict market growth.

Key features of the study:

  • This report provides in-depth analysis of the global veterinary dermatology drugs market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global veterinary dermatology drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Zoetis Inc., Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Virbac, Vetoquinol S.A., Dechra Pharmaceuticals PLC, Bayer AG, Ceva Sante Animale, Kindred Biosciences, Inc., and IDEXX Laboratories, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global veterinary dermatology drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary dermatology drugs market

Detailed Segmentation:

  • Global Veterinary Dermatology Drugs Market, By Type of Drug:
    • Antibiotics
    • Antifungal drugs
    • Anti-inflammatory drugs
    • Immunotherapy drugs
    • Parasiticides
    • Others
  • Global Veterinary Dermatology Drugs Market, By Animal Type:
    • Dogs
    • Cats
    • Horses
    • Others
  • Global Veterinary Dermatology Drugs Market, By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Company Profiles:
    • Zoetis Inc.
    • Elanco Animal Health Incorporated
    • Boehringer Ingelheim International GmbH
    • Virbac
    • Vetoquinol S.A.
    • Dechra Pharmaceuticals PLC
    • Bayer AG
    • Ceva Sante Animale
    • Kindred Biosciences, Inc.
    • IDEXX Laboratories, Inc.
Product Code: CMI5642

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type Of Drug
    • Market Snapshot, By Animal Type
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Growing prevalence of skin disease in animals
  • Rise in number of pet owners
    • Restraints
  • Lack of awareness across developing countries
  • Side-effects associated with drugs
  • Strict approval regulations
    • Opportunities
  • Increasing investment by government and private sectors
  • Development of cutting-edge therapies
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Veterinary Dermatology Drugs Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Veterinary Dermatology Drugs Market , By Type of Drug, 2017-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Antibiotics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Antifungal drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Anti-inflammatory drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Immunotherapy drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Parasiticides
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)

6. Global Veterinary Dermatology Drugs Market , By Animal Type, 2017-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Dogs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Billion)
  • Cats
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Billion)
  • Horses
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Billion)

7. Global Veterinary Dermatology Drugs Market , By Region, 2017-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2017 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017-2030,(US$ Bn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017-2030,(US$ Bn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017-2030,(US$ Bn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017-2030,(US$ Bn)
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017-2030,(US$ Bn)

8. Competitive Landscape

  • Zoetis Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Elanco Animal Health Incorporated
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Boehringer Ingelheim International GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Virbac
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Vetoquinol S.A.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Dechra Pharmaceuticals PLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Ceva Sante Animale
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Kindred Biosciences, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • IDEXX Laboratories, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!